BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  MAP Pharmaceuticals, Inc. Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares of Common Stock

  August 30, 2012

   · 

  2 min read
• Policy

  Bayer HealthCare Pharmaceuticals Submits New Drug Application for Regorafenib for the Treatment of Gastrointestinal Stromal Tumors (GIST)

  August 30, 2012

   · 

  6 min read
• Biotech Bay

  Delcin Consulting Group Release: Introducing a Revolutionary Approach to Consulting

  August 30, 2012

   · 

  1 min read
• Business

  Aerpio Completes $27 Million Series A Financing

  August 30, 2012

   · 

  2 min read
• Policy

  Johnson & Johnson Prostate Cancer Drug Gets FDA Priority Review Status

  August 30, 2012

   · 

  5 min read
• Biotech Beach

  Edwards Lifesciences Corporation Insiders Keep Selling

  August 30, 2012

   · 

  1 min read
• Business

  Life Technologies and Sino Biological Inc. Sign Strategic Partnership Agreement for Global Distribution and Product Development

  August 30, 2012

   · 

  5 min read
• Policy

  Exelixis, Inc. Provides Update on ODAC Panel for Cabozantinib

  August 30, 2012

   · 

  1 min read
• Drug Development

  Elan Corporation PLC Announces Dosing of First Patient in Phase 2 Trial of ELND005 (Scyllo-inositol) in Bipolar Disorder

  August 30, 2012

   · 

  1 min read
• SureGene, LLC and PGXL Laboratories launch the SureGene Test for Antipsychotic and Antidepressant Response (STA2R)

  August 30, 2012

   · 

  3 min read